Quantitative comparison of expression with adeno-associated virus (AAV-2) brain-specific gene cassettes

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Gene Therapy

• Publication date

  2001-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.gt.3301529PMID 11571569
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recombinant adeno-associated virus type 2, 4, and 5 vectors: transduction of variant cell types and regions in the mammalian central nervous system.

  2000cited by this paper
• AlphaVbeta5 integrin: a co-receptor for adeno-associated virus type 2 infection.

  1999cited by this paper
• Adeno-associated virus 2 co-receptors?

  1999cited by this paper
• A system for the propagation of adenoviral vectors with genetically modified receptor specificities

  1999cited by this paper
• Dynamin Is Required for Recombinant Adeno-Associated Virus Type 2 Infection

  1999cited by this paper
• Integrin Subunit Gene Expression Is Regionally Differentiated in Adult Brain

  1999cited by this paper
• Neuronal and glial cell type-specific promoters within adenovirus recombinants restrict the expression of the apoptosis-inducing molecule Fas ligand to predetermined brain cell types, and abolish peripheral liver toxicity.

  1999cited by this paper
• Use of herpes simplex virus type 1 for transgene expression within the nervous system.

  1999cited by this paper
• Modification of an Adenoviral Vector with Biologically Selected Peptides: A Novel Strategy for Gene Delivery to Cells of Choice

  1999cited by this paper
• Global CNS gene transfer for a childhood neurogenetic enzyme deficiency: Canavan disease.

  1999cited by this paper
• Highly Purified Recombinant Adeno-Associated Virus Vectors Are Biologically Active and Free of Detectable Helper and Wild-Type Viruses

  1999cited by this paper
• A 110-kDa nuclear shuttle protein, nucleolin, specifically binds to adeno-associated virus type 2 (AAV-2) capsid.

  1999cited by this paper
• αVβ5 integrin: a co-receptor for adeno-associated virus type 2 infection

  1999cited by this paper
• Efficient CFTR expression from AAV vectors packaged with promoters – the second generation

  1999cited by this paper
• Adeno-Associated Virus-Mediated Gene Transfer to the Brain: Duration and Modulation of Expression

  1999cited by this paper
• Diverse Stabilities of Expression in the Rat Brain from Different Cellular Promoters in a Helper Virus-Free Herpes Simplex Virus Type 1 Vector System

  1999cited by this paper
• Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield

  1999cited by this paper
• Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2

  1999cited by this paper
• Genetic capsid modifications allow efficient re-targeting of adeno-associated virus type 2

  1999cited by this paper
• AAVant-garde gene therapy

  1999cited by this paper
• Peroral gene therapy of lactose intolerance using an adeno-associated virus vector

  1998cited by this paper
• Membrane-Associated Heparan Sulfate Proteoglycan Is a Receptor for Adeno-Associated Virus Type 2 Virions

  1998cited by this paper
• Polarity Influences the Efficiency of Recombinant Adenoassociated Virus Infection in Differentiated Airway Epithelia

  1998cited by this paper
• Adeno-Associated Virus Vector-Mediated Transgene Integration into Neurons and Other Nondividing Cell Targets

  1998cited by this paper
• Selective and Rapid Uptake of Adeno-Associated Virus Type 2 in Brain

  1998cited by this paper
• Adeno-Associated Virus Type 2-Mediated Gene Transfer: Correlation of Tyrosine Phosphorylation of the Cellular Single-Stranded D Sequence-Binding Protein with Transgene Expression in Human Cells In Vitro and Murine Tissues In Vivo

  1998cited by this paper
• In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vector

  1998cited by this paper
• Recombinant adeno-associated virus vector: use for transgene expression and anterograde tract tracing in the CNS.

  1998cited by this paper
• Neuron-specific transduction in the rat septohippocampal or nigrostriatal pathway by recombinant adeno-associated virus vectors.

  1998cited by this paper
• Woodchuck Hepatitis Virus Contains a Tripartite Posttranscriptional Regulatory Element

  1998cited by this paper
• Gene transfer and expression in oligodendrocytes under the control of myelin basic protein transcriptional control region mediated by adeno-associated virus

  1998cited by this paper
• Fibroblast growth factor receptor-1 expression in the cortex and hippocampus in Alzheimer's disease.

  1998cited by this paper
• Optimization of Plasmid Vectors for High-Level Expression in Lung Epithelial Cells

  1997cited by this paper
• Transgene expression of plasmid DNAs directed by viral or neural promoters in the rat brain.

  1997cited by this paper
• Gene transfer by adeno-associated virus vectors into the central nervous system.

  1997cited by this paper
• Efficient transduction of green fluorescent protein in spinal cord neurons using adeno-associated virus vectors containing cell type-specific promoters

  1997cited by this paper
• Subcellular compartmentalization of adeno-associated virus type 2 assembly

  1997cited by this paper
• Sequences in the proximal 5′ flanking region of the rat neuron-specific enolase (NSE) gene are sufficient for cell type-specific reporter gene expression

  1997cited by this paper
• Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector

  1997cited by this paper
• The packaging capacity of adeno‐associated virus (AAV) and the potential for wild‐type‐plus AAV gene therapy vectors

  1997cited by this paper
• Quantitative Analysis of the Packaging Capacity of Recombinant Adeno-Associated Virus

  1996cited by this paper
• Adeno-associated virus type 2 binds to a 150-kilodalton cell membrane glycoprotein.

  1996cited by this paper
• Efficient transduction of human neurons with an adeno-associated virus vector.

  1996cited by this paper
• Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector.

  1996cited by this paper
• Comparison of promoter strengths on gene delivery into mammalian brain cells using AAV vectors.

  1996cited by this paper
• Developmental and FGF-2-mediated regulation of syndecans (1-4) and glypican in oligodendrocytes.

  1996cited by this paper
• Role of the hepatitis B virus posttranscriptional regulatory element in export of intronless transcripts

  1995cited by this paper
• Dopaminergic regulation of a transfected preproenkephalin promoter in primary rat astrocytes in vitro and in vivo.

  1994cited by this paper
• Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain

  1994cited by this paper
• Expression and distribution of functional intergrins in rat CNS glia

  1994cited by this paper
• Efficient gene transfer into nondividing cells by adeno-associated virus-based vectors

  1994cited by this paper
• Mutations in the carboxy terminus of adeno-associated virus 2 capsid proteins affect viral infectivity: lack of an RGD integrin-binding motif.

  1994cited by this paper
• Herpesvirus-mediated gene delivery into the rat brain: specificity and efficiency of the neuron-specific enolase promoter

  1993cited by this paper
• Developmental regulation of neural response to FGF-1 and FGF-2 by heparan sulfate proteoglycan.

  1993cited by this paper
• Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector.

  1993cited by this paper
• Gene Transfer into Mammalian Central Nervous System Using Herpes Virus Vectors: Extended Expression of Bacterial lacZ in Neurons Using the Neuron-Specific Enolase Promoter

  1992cited by this paper
• Transgenic mice expressing beta-galactosidase in mature neurons under neuron-specific enolase promoter control.

  1990cited by this paper
• Differential Effects of Polyadenylation Regions on Gene Expression in Mammalian Cells

  1986cited by this paper
• The cell bodies of origin of sympathetic and sensory axons in some skin and muscle nerves of the cat hindlimb

  1983cited by this paper

• Engineered mitochondria in diseases: mechanisms, strategies, and applications

  2025cites this paper
• NA Comparison of Transduction Efficiency of Medial Septal Neurons by Adeno-Associated Viruses with Three Promoters.

  2025cites this paper
• Revolution of AAV in Drug Discovery: From Delivery System to Clinical Application

  2025cites this paper
• Regulatory Elements for Gene Therapy of Epilepsy

  2025cites this paper
• Dnmt3a1 regulates hippocampus-dependent memory via the downstream target Nrp1

  2024influential citation
• Quantification of full and empty particles of adeno-associated virus vectors via a novel dual fluorescence-linked immunosorbent assay

  2024cites this paper
• Adeno-Associated Viral Vectors in the Treatment of Epilepsy

  2024cites this paper
• Whole-Body Disposition and Physiologically Based Pharmacokinetic Modeling of Adeno-Associated Viruses and the Transgene Product.

  2023cites this paper
• No evidence from complementary data sources of a direct glutamatergic projection from the mouse anterior cingulate area to the hippocampal formation

  2023cites this paper
• Combinatorial gene therapy for epilepsy: Gene sequence positioning and AAV serotype influence expression and inhibitory effect on seizures

  2023cites this paper
• Negative regulation of TREM2-mediated C9orf72 poly-GA clearance by the NLRP3 inflammasome.

  2023cites this paper
• Development of mitochondrial gene-editing strategies and their potential applications in mitochondrial hereditary diseases: a review.

  2023cites this paper
• Prospects for gene replacement therapies in amyotrophic lateral sclerosis

  2022cites this paper
• An efficient rAAV vector for protein expression in cortical parvalbumin expressing interneurons

  2022cites this paper
• Expression Cassette Design and Regulation of Transgene Expression

  2021cites this paper
• Canavan Disease as a Model for Gene Therapy-Mediated Myelin Repair

  2021cites this paper
• Genetic Constructs for the Control of Astrocytes’ Activity

  2021influential citation
• Hearing impairment: new frontiers of regenerative medicine

  2021cites this paper
• Chemogenetics: Beyond Lesions and Electrodes

  2021cites this paper
• AAV9-mediated gene delivery of MCT1 to oligodendrocytes does not provide a therapeutic benefit in a mouse model of ALS

  2021cites this paper
• Reduction of advanced tau-mediated memory deficits by the MAP kinase p38γ

  2020cites this paper
• In Vivo Expression of Reprogramming Factor OCT4 Ameliorates Myelination Deficits and Induces Striatal Neuroprotection in Huntington’s Disease

  2020cites this paper
• MeCP2 gates spatial learning-induced alternative splicing events in the mouse hippocampus

  2020cites this paper
• DNA‐editing enzymes as potential treatments for heteroplasmic mtDNA diseases

  2020cites this paper
• rAAV-Mediated Cochlear Gene Therapy: Prospects and Challenges for Clinical Application

  2020cites this paper
• MeCP2 gates spatial learning-induced alternative splicing events in the mouse 1 hippocampus 2

  2020cites this paper
• CNS Transduction Benefits of AAV-PHP.eB over AAV9 Are Dependent on Administration Route and Mouse Strain

  2020cites this paper
• Mimicking Age-Associated Gadd45γ Dysregulation Results in Memory Impairments in Young Adult Mice

  2019cites this paper
• Adeno-Associated Virus Technologies and Methods for Targeted Neuronal Manipulation

  2019cites this paper
• Corticostriatal stimulation compensates for medial frontal inactivation during interval timing

  2019cites this paper
• Systemic AAV vectors for widespread and targeted gene delivery in rodents

  2019cites this paper
• Adult hippocampal MeCP2 preserves the genomic responsiveness to learning required for long‐term memory formation

  2018influential citation
• A MicroRNA-Based Gene-Targeting Tool for Virally Labeling Interneurons in the Rodent Cortex.

  2018cites this paper
• Bile diversion, a bariatric surgery, and bile acid signaling reduce central cocaine reward

  2018cites this paper
• Silencing of transgene expression in mammalian cells by DNA methylation and histone modifications in gene therapy perspective

  2018cites this paper
• Gene therapy mediated seizure suppression in Genetic Generalised Epilepsy: Neuropeptide Y overexpression in a rat model.

  2018cites this paper
• A viral approach to translatome profiling of CA1 neurons during associative recognition memory formation

  2018cites this paper
• Widespread and targeted gene expression by systemic AAV vectors: Production, purification, and administration

  2018cites this paper
• Developing an astrocyte-selective AAV-ADAMTS4 gene therapy to promote repair after spinal cord injury

  2018cites this paper
• Pushing the Right Buttons: Improving Efficacy of Therapeutic DNA Vectors

  2017cites this paper
• AAV-mediated transfer of RhoA shRNA and CNTF promotes retinal ganglion cell survival and axon regeneration.

  2017cites this paper
• Hypothalamic over-expression of VGF in the Siberian hamster increases energy expenditure and reduces body weight gain

  2017cites this paper
• Adeno-Associated Virus (AAV) as a Vector for Gene Therapy

  2017cites this paper
• 3 Systemically administered AAV 9-sTRAIL combats invasive glioblastoma in a patient-derived orthotopic xenograftmodel

  2017cites this paper
• Inclusion of the Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element Enhances AAV2-Driven Transduction of Mouse and Human Retina

  2016cites this paper
• Cell-Specific Targeting of Genetically Encoded Tools for Neuroscience.

  2016cites this paper
• Systemically administered AAV9-sTRAIL combats invasive glioblastoma in a patient-derived orthotopic xenograft model

  2016cites this paper
• Controlling AAV Tropism in the Nervous System with Natural and Engineered Capsids.

  2016cites this paper
• Long-Term Follow-Up After Gene Therapy for

  2016cites this paper
• Deimmunization for gene therapy: host matching of synthetic zinc finger constructs enables long-term mutant Huntingtin repression in mice

  2016cites this paper
• Considering optogenetic stimulation for cochlear implants.

  2015cites this paper
• Fluorescent Calcium Indicator Protein Expression in the Mouse Brain Using Recombinant Adeno-Associated Viruses.

  2015cites this paper
• Non-viral therapeutic approaches to ocular diseases: An overview and future directions.

  2015cites this paper
• Adeno-associated viruses ( AAV ) plasmids < R > ( see Discussion ) AAV packaging plasmids Set 1 : pDP 1 and pDP

  2015cites this paper
• Viral expression cassette elements to enhance transgene target specificity and expression in gene therapy.

  2015influential citation
• Gene Therapy for the Nervous System: Challenges and New Strategies

  2014cites this paper
• Optimization of AAV expression cassettes to improve packaging capacity and transgene expression in neurons

  2014cites this paper
• Adenosine kinase, glutamine synthetase and EAAT2 as gene therapy targets for temporal lobe epilepsy

  2014cites this paper
• Methods for gene transfer to the central nervous system.

  2014influential citation
• AAV-Mediated Overexpression of Neuroserpin in the Hippocampus Decreases PSD-95 Expression but Does Not Affect Hippocampal-Dependent Learning and Memory

  2014cites this paper
• Optimization of eGFP expression using a modified baculovirus expression system.

  2014cites this paper
• Targeted CNS delivery using human MiniPromoters and demonstrated compatibility with adeno-associated viral vectors

  2014cites this paper
• IGF-I redirects doublecortin-positive cell migration in the normal adult rat brain.

  2013cites this paper
• Hypothalamic EphA5 Facilitates Counterregulatory Responses

  2013cites this paper
• A compact dual promoter adeno-associated viral vector for efficient delivery of two genes to dorsal root ganglion neurons

  2013cites this paper
• Preferential Lentiviral Targeting of Astrocytes in the Central Nervous System

  2013cites this paper
• Development of tools in mouse for future gene therapy : promoters for the CNS, and novel expression models of neural stem cell regulator, NR2E1.

  2013cites this paper
• A Single Intravenous AAV9 Injection Mediates Bilateral Gene Transfer to the Adult Mouse Retina

  2013cites this paper
• Hypothalamic EphA 5 Facilitates Counterregulatory Responses Possible Role for Bidirectional Signaling Leading to Bistability That Enhances Responsiveness to Hypoglycemia

  2013cites this paper
• The use of specific AAV serotypes to stably transduce primary CNS neuron cultures.

  2012cites this paper
• The advent of AAV9 expands applications for brain and spinal cord gene delivery

  2012cites this paper
• Long-Term Follow-Up After Gene Therapy for Canavan Disease

  2012cites this paper
• Ectopic expression of TrKA in the adult rat basal ganglia induces both nerve growth factor‐dependent and ‐independent neuronal responses

  2012cites this paper
• The assessment of adeno‐associated vectors as potential intrinsic treatments for brainstem axon regeneration

  2012cites this paper
• Avian Adeno-Associated Virus Vector Efficiently Transduces Neurons in the Embryonic and Post-Embryonic Chicken Brain

  2012cites this paper
• Restricted Transgene Expression in the Brain with Cell-Type Specific Neuronal Promoters

  2012influential citation
• Nuclear calcium-VEGFD signaling controls maintenance of dendrite arborization necessary for memory formation.

  2011cites this paper
• Genetic Approaches to Investigate the Role of CREB in Neuronal Plasticity and Memory

  2011cites this paper
• Expression of microbial rhodopsins in retinal neurons with subcellular targeting motifs: for the study of the structure/function of aii amacrine cells and for vision restoration

  2011cites this paper
• Comparison of the efficacy of four viral vectors for transducing hypothalamic magnocellular neurosecretory neurons in the rat supraoptic nucleus.

  2011cites this paper
• Neuregulin 1-Erbb4 in the rodent prefrontal cortex: Investigations of schizophrenia-related behaviours and signalling pathways

  2011cites this paper
• Genetic analysis of emotional memory in AMPA and NMDA receptor mutant mice

  2011cites this paper
• Differential transduction following basal ganglia administration of distinct pseudotyped AAV capsid serotypes in nonhuman primates.

  2010cites this paper
• EUROPEAN SCHOOL OF MOLECULAR MEDICINE

  2010cites this paper
• The combined use of viral transcriptional and post-transcriptional regulatory elements to improve baculovirus-mediated transient gene expression in human embryonic stem cells.

  2010cites this paper
• Differential Transduction Following Basal Ganglia Administration of Distinct Pseudotyped AAV Capsid Serotypes in Nonhuman Primates.

  2010cites this paper
• Adult-onset hippocampal-specific neuropeptide Y overexpression confers mild anxiolytic effect in mice.

  2010cites this paper
• A dual promoter lentiviral vector for the in vivo evaluation of gene therapeutic approaches to axon regeneration after spinal cord injury

  2010cites this paper
• Intrinsic and Extrinsic Factors for the Regeneration of Brainstem Axons after Spinal Cord Injury

  2010cites this paper
• Nuclear Calcium Signaling Controls Expression of a Large Gene Pool: Identification of a Gene Program for Acquired Neuroprotection Induced by Synaptic Activity

  2009cites this paper
• Versatile Somatic Gene Transfer for Modeling Neurodegenerative Diseases

  2009cites this paper
• Transcriptional targeting to brain cells: Engineering cell type-specific promoter containing cassettes for enhanced transgene expression.

  2009cites this paper
• Efficient gene delivery and selective transduction of glial cells in the mammalian brain by AAV serotypes isolated from nonhuman primates.

  2009cites this paper
• Rapid, reproducible transduction of select forebrain regions by targeted recombinant virus injection into the neonatal mouse brain.

  2009cites this paper
• FRAGILE X MENTAL RETARDATION PROTEIN REPLACEMENT RESTORES HIPPOCAMPAL SYNAPTIC FUNCTION IN A MOUSE MODEL OF FRAGILE X SYNDROME

  2009cites this paper
• Engineered lentiviral vector targeting astrocytes In vivo

  2009cites this paper
• Long-term AAV vector gene and protein expression in mouse brain from a small pan-cellular promoter is similar to neural cell promoters

  2009cites this paper
• Viral strategies for studying the brain, including a replication‐restricted self‐amplifying delta‐G vesicular stomatis virus that rapidly expresses transgenes in brain and can generate a multicolor golgi‐like expression

  2009cites this paper
• A new rodent model of Parkinson s Disease based on neuron specific downregulation of glutathione production.

  2009cites this paper
• Targeting Homer genes using adeno-associated viral vector: lessons learned from behavioural and neurochemical studies

  2008influential citation